Msn Laboratories Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LENALIDOMIDE, with a corresponding US DMF Number 31590.
Remarkably, this DMF maintains an Active status since its submission on March 28, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 05, 2025, and payment made on December 31, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II